[EN] COMPOUNDS FOR PIM KINASE INHIBITION AND FOR TREATING MALIGNANCY [FR] COMPOSÉS POUR L'INHIBITION DE LA KINASE PIM ET POUR LE TRAITEMENT DE MALIGNITÉ
[EN] COMPOUNDS FOR PIM KINASE INHIBITION AND FOR TREATING MALIGNANCY [FR] COMPOSÉS POUR L'INHIBITION DE LA KINASE PIM ET POUR LE TRAITEMENT DE MALIGNITÉ
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
Isoquinoline synthesis by C-H activation/annulation using vinyl acetate as an acetylene equivalent
作者:Nicola J. Webb、Steven A. Raw、Stephen P. Marsden
DOI:10.1016/j.tet.2018.05.063
日期:2018.9
Vinyl acetate is used as an acetylene equivalent in rhodium(III)-catalysed C-H activation/annulation with aryl ketoxime esters. Extension to an aldoxime ester allows for a concise formal synthesis of decumbenine B.
COMPOUNDS FOR PIM KINASE INHIBITION AND FOR TREATING MALIGNANCY
申请人:Nikolich Karoly
公开号:US20100160297A1
公开(公告)日:2010-06-24
The present invention relates to the compounds of formula I as well as to their use as PIM kinase inhibitors and, thereby, their use for treating oncological diseases, particularly of the hematopoietic system, the liver and the prostate gland.
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.